Parpia, Sameer

Affiliations

Faculty of Health Sciences , McMaster University
Joint Appointment, Health Research Methods, Evidence, and Impact , Faculty of Health Sciences
Assistant Professor, Oncology , Faculty of Health Sciences

Research Areas

Biostatistics (RA)
Cardiorespiratory Medicine and Haematology (RA)
Epidemiology (RA)
Oncology and Carcinogenesis (RA)

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Background
Contact
View All

selected scholarly activity

academic article
- Perioperative Optimization With Nutritional Supplements in Patients Undergoing Gastrointestinal Surgery for Cancer (PROGRESS): Protocol for a Feasibility Randomized Controlled Trial.. JMIR Research Protocols. 7:e10491. 2018
- Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism.. Blood. 131:2151-2160. 2018
- Evaluation of a specialized oncology nursing supportive care intervention in newly diagnosed breast and colorectal cancer patients following surgery: a cluster randomized trial.. Supportive Care in Cancer. 26:1533-1541. 2018
- Does the Addition of Biologic Agents to Chemotherapy in Patients with Unresectable Colorectal Cancer Metastases Result in a Higher Proportion of Patients Undergoing Resection? A Systematic Review and Meta-analysis.. Journal of Gastrointestinal Surgery. 22:523-528. 2018
- Association of Waist-Hip Ratio to Sudden Cardiac Death and Severe Coronary Atherosclerosis in Medicolegal Autopsies.. American Journal of Forensic Medicine and Pathology. 38:226-228. 2017
- Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.. International Journal of Radiation Oncology Biology Physics. 99:90-93. 2017
- Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.. Breast Cancer Research and Treatment. 164:13-25. 2017
- Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.. Clinical Lung Cancer. 18:250-254. 2017
- D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.. Thrombosis Research. 146:119-125. 2016
- Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel.. Vascular Medicine. 21:400-407. 2016
- Does the risk of peritoneal dialysis-associated peritonitis vary by time on treatment?. Clinical Nephrology. 85:209-214. 2016
- Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study.. Journal of Thrombosis and Haemostasis. 14:504-509. 2016
- The prevalence and significance of a short QT interval in 18,825 low-risk individuals including athletes.. British Journal of Sports Medicine. 50:124-129. 2016
- Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis.. International Journal of Radiation Oncology Biology Physics. 91:968-976. 2015
- D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.. Annals of Internal Medicine. 162:27-34. 2015
- Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer.. BMJ Open. 4:e006531. 2014
- Treating clots in cancer: moving closer to an answer?. The Lancet Haematology. 1:e6-e7. 2014
- Improvement in the quality of abstracts in major clinical journals since CONSORT extension for abstracts: a systematic review.. Controlled Clinical Trials Contemporary Clinical Trials. 38:245-250. 2014
- Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.. Breast Cancer Research and Treatment. 146:153-162. 2014
- Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy.. Annals of Oncology. 25:992-998. 2014
- Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times.. SpringerPlus. 3:323. 2014
- Evaluation of confidence intervals for the kappa statistic when the assumption of marginal homogeneity is violated. Computational Statistics. 28:2709-2718. 2013
- Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.. Journal of Clinical Oncology. 31:4038-4045. 2013
- Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer.. Journal of Clinical Oncology. 31:3758-3763. 2013
- Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.. BMC Medical Research Methodology. 13:44. 2013
- Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial.. Annals of Internal Medicine. 158:93-100. 2013
- Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.. Thrombosis Research. 130:894-900. 2012
- Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.. Annals of Internal Medicine. 155:653-W203. 2011
- Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.. Controlled Clinical Trials Contemporary Clinical Trials. 32:829-833. 2011
- PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.. Journal of Thrombosis and Haemostasis. 8:1959-1965. 2010
- Long-term results of hypofractionated radiation therapy for breast cancer.. New England Journal of Medicine. 362:513-520. 2010
conference paper
- Systematic Review and Meta-Analysis of the Effect of Pre-Operative PET/PET-CT in the Management of Patients With Potentially Resectable Colorectal Cancer Liver Metastasis. Annals of Surgical Oncology. S124-S125. 2018
- Long-Term Outcomes of Microinvasive Breast Cancer in the Canadian Hypofractionation Trial. International Journal of Radiation Oncology Biology Physics. S56-S57. 2017
- Randomized Study of Quality of Life in Patients with High-Risk Prostate Cancer Undergoing Radiotherapy: Role of Pelvic Nodal IMRT. International Journal of Radiation Oncology Biology Physics. E211-E212. 2017
- Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. International Journal of Radiation Oncology Biology Physics. S59-S59. 2015
- Early Results of a Quality Assurance Program in a Randomized Trial of Stereotactic Body Radiotherapy for Stage I Medically Inoperable Lung Cancer. Journal of Thoracic Oncology. S327-S327. 2015
- Evaluation of Pseudoprogression in Patients With Glioblastoma (EPPIG). International Journal of Radiation Oncology Biology Physics. S288-S288. 2014
- Performance of fibrin monomer in the evaluation of patients with suspected pulmonary embolism. Journal of Thrombosis and Haemostasis. 733-733. 2013
- Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3D Conformal External Beam Radiation Therapy (3D CRT). International Journal of Radiation Oncology Biology Physics. 21-22. 2013
- Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis.. Blood. 2012
- Claudin-Low Breast Cancer; a Molecular Subtype Associated with Poor Prognosis. Modern Pathology. 34A-34A. 2012
- Claudin-Low Breast Cancer; a Molecular Subtype Associated with Poor Prognosis. Laboratory Investigation. 34A-34A. 2012
- Morphological Characteristics of HER2 Over-Expressing and Basal-Like Breast Cancers and the Association between Lymphocytic Tumor Infiltrate and Prognosis. Modern Pathology. 25A-25A. 2012
- Morphological Characteristics of HER2 Over-Expressing and Basal-Like Breast Cancers and the Association between Lymphocytic Tumor Infiltrate and Prognosis. Laboratory Investigation. 25A-25A. 2012
- Four weeks vs. 12 weeks dosing interval for stable patients on warfarin: a randomized trial. Journal of Thrombosis and Haemostasis. 446-446. 2011
- A randomized phase III trial of magic mouthwash and sucralfate versus benzydamine hydrochloride for prophylaxis of radiation-induced oral mucositis in head and neck cancer.. Journal of Clinical Oncology. 2011
- Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: A phase II randomized study. Journal of Clinical Oncology. 2009
- Predictors of recurrent thrombosis and anticoagulant-related bleeding in patients with cancer. Journal of Clinical Oncology. 2009
- DELTA: A Randomized Trial of Decongestive Lymphatic Therapy for Women with Lymphedema following Treatment for Breast Cancer. International Journal of Radiation Oncology Biology Physics. S53-S53. 2009
- LDR Prostate Brachytherapy: Dosimetric Evaluation of Stabilizing Needles and Seminal Vesicle Implants. International Journal of Radiation Oncology Biology Physics. S353-S353. 2009